Clinical presentation and initial diagnosis

Adrenocortical Carcinoma: Basic Science and Clinical Concepts

Volumn , Issue , 2011, Pages 31-47

  Allolio, Bruno ^a   Fassnacht, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865245987     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-77236-3_4     Document Type: Chapter

References (96)

1. Abiven G et al (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91(7):2650-2655
2. Crucitti F et al (1996) The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119(2):161-170
3. Dackiw AP et al (2001) Adrenal cortical carcinoma. World J Surg 25(7):914-926
4. Icard P et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25(7):891-897
5. Kendrick ML et al (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136(5):543-549
6. Koschker AC et al (2006) Adrenocortical carcinoma - improving patient care by establishing new structures. Exp Clin Endocrinol Diabetes 114(2):45-51
7. Schulick RD, Brennan MF (1999) Adrenocortical carcinoma. World J Urol 17(1):26-34
8. Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72(11):3145-3155
9. Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23(2):273-289
10. Didolkar MS et al (1981) Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47(9):2153-2161
11. Favia G et al (2001) Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 25(6):735-738
12. Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112(6):963-970; discussion 970-971
13. Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92(5):1113-1121
14. Wajchenberg B et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4):711-736
15. Newell-Price J et al (2006) Cushing's syndrome. Lancet 367(9522):1605-1617
16. Stewart PM et al (1995) 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 80(12):3617-3620
17. Moreno S et al (2004) Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases. Surgery 136(6):1192-1198
18. Gabrilove J et al (1965) Feminizing adrenocortical tumors in the male: a review of 52 cases including a case report. Medicine 44:37-39
19. Lanigan D et al (1993) A feminizing adrenocortical carcinoma presenting with gynaecomastia. Postgrad Med J 69(812):481-483
20. Allolio B et al (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60:273-287
21. Seccia TM et al (2005) Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 12(1):149-159
22. Barzon L et al (2005) Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma. Eur J Endocrinol 153(5):629-636
23. Hisamatsu H et al (2002) Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence. BJU Int 90(9):971-972
24. Hyodo T et al (1977) Adrenocortical carcinoma and hypoglycemia: evidence for production of nonsuppressible insulin-like activity by the tumor. J Clin Endocrinol Metab 44(6):1175-1184
25. Luton JP et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322(17):1195-1201
26. Falchuk KR (1973) Inappropriate antidiuretic hormone-like syndrome associated with an adrenocortical carcinoma. Am J Med Sci 266(5):393-395
27. Yamanaka K et al (2000) A case of renin-producing adrenocortical cancer. Endocr J 47(2):119-125
28. Oka T et al (1996) Erythropoietin-producing adrenocortical carcinoma. Urol Int 56(4):246-249
29. Fragoso MC et al (2007) An inhibin B and estrogen-secreting adrenocortical carcinoma leading to selective FSH suppression. Horm Res 67(1):7-11
30. Pegoli W Jr. et al (1987) Ectopic calcitonin in adrenocortical carcinoma: a new tumor marker. J Pediatr Surg 22(12):1183-1184
31. Bussani R et al (2003) Chance diagnosis of low stage non-metastasized adrenal cortical carcinoma in a young woman with retroperitoneal hemorrhage. Pathol Res Pract 199(11):761-763
32. Suyama K et al (2007) Spontaneous rupture of adrenocortical carcinoma. Am J Surg 194(1):77-78
33. Chesson JP, Theodorescu D (2002) Adrenal tumor with caval extension - case report and review of the literature. Scand J Urol Nephrol 36(1):71-73
34. Hisham AN et al (2003) Large adrenocortical carcinoma extending into the inferior vena cava and right atrium. Asian J Surg 26(1):40-42
35. Radecka E et al (2003) An unusual case of tumor thrombus in the inferior vena cava. A case report. Acta Radiol 44(2):160-161
36. Yeh MW et al (2006) Virilizing adrenocortical carcinoma with cavoatrial extension. Am J Surg 192(2):209-210
37. Fassnacht M et al (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115(2):243-250
38. Bakthavathsalam G et al (2008) Nonfunctioning adrenocorticalcarcinoma. Int Surg 93(2):81-87
39. Brand TC et al (2001) Adrenal cortical carcinoma presenting as right varicocele. J Urol 165(2):503
40. Wright CB et al (2008) Adrenocortical tumor with left renal vein, vena cava and intrahepatic venous extension. J Cardiovasc Surg (Torino) 49(1):79-81
41. Carbonnel F et al (1988) Acute Budd-Chiari syndrome as first manifestation of adrenocortical carcinoma. J Clin Gastroenterol 10(4):441-444
42. Schteingart DE et al (2001) Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. J Clin Endocrinol Metab 86(8):3968-3974
43. Durusu M et al (2002) Adrenal cortical carcinoma presenting initially with radius metastasis. Clin Oncol (R Coll Radiol) 14(1):83-84
44. Solans R et al (2001) [Bone metastases as presentation of adrenocortical carcinoma]. Med Clin (Barc) 116(2):76-77
45. Macfarlane DA (1958) Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R C Surg Engl 23(3):155-186
46. Fassnacht M et al (2004) Adrenal tumors: how to establish malignancy? J Endocrinol Invest 27(4):387-399
47. Elamin MB et al (2008) Accuracy of Diagnostic Tests for Cushing's Syndrome: a Systematic Review and Metaanalyses. J Clin Endocrinol Metab 93(5):1553-1562
48. Nieman LK et al (2008) The Diagnosis of Cushing's Syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526-1540
49. Boyle JG et al (2007) Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J Clin Endocrinol Metab 92(12):4602-4608
50. Eisenhofer G (2003) Editorial: biochemical diagnosis of pheochromocytoma - is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab 88(2):550-552
51. Pacak K et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3(2):92-102
52. Perry CG et al (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf) 66(5):703-708
53. Unger N et al (2006) Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154(3):409-417
54. Vaclavik J et al (2007) Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 25(7):1427-1431
55. Arlt W et al (2008) Steroid profiling in the diagnosis and monitoring of adrenocortical cancer - results of the EURINE ACC Study of the European Network For The Study Of Adrenal Tumors (ENS@T). Abstracts of the 90th annual meeting of the Endocrine Society (San Francisco): OR40-2
56. Johanssen S, et al (2010) Need for improvement in the clinical management of patients with adrenocortical carcinoma in Germany. Dt Aerzteblatt in press
57. Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027-2037
58. Friedrich-Rust M et al (2008) Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions. AJR Am J Roentgenol 191(6):1852-1860
59. Bauditz J et al (2008) Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound. Oncol Rep 19(5):1135-1139
60. Boland GW et al (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201-204
61. Caoili EM et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222(3):629-633
62. Hamrahian AH et al (2005) Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland Clinic experience. J Clin Endocrinol Metab 90(2):871-877
63. Heinz-Peer G et al (2007) Imaging of adrenal masses. Curr Opin Urol 17(1):32-38
64. Ilias I et al (2007) The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14(3):587-599
65. Szolar DH et al (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2):479-485
66. Park BK et al (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243(3):760-765
67. Honigschnabl S et al (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41(2):113-122
68. Al-Hawary MM et al (2005) Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 19(2):277-292
69. Faria JF et al (2007) Adrenal masses: characterization with in vivo proton MR spectroscopy - initial experience. Radiology 245(3):788-797
70. Groussin L et al (2009) 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94(5):1713-1722
71. Boland GW et al (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192(4):956-962
72. Okada M et al (2009) Adrenal masses: the value of additional fluorodeoxy-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions. Ann Nucl Med 23(4):349-354
73. Leboulleux S et al (2006) Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 91(3):920-925
74. Mackie GC et al (2006) Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 91(7):2665-271
75. DeLellis RA et al (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs (IARC), Lyon, France, pp 136
76. Sullivan M et al (1978) Adrenal cortical carcinoma. J Urol 120(6):660-665
77. Quayle FJ et al (2007) Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery 142(4):497-502; discussion 502-504
78. Casola G et al (1986) Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology 159(3):733-735
79. Kloos RT et al (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460-484
80. Lumachi F et al (2001) Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors. Cancer 93(5):323-329
81. McCorkell SJ, Niles NL (1985) Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol 145(1):113-114
82. Yankaskas B et al (1986) Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest Radiol 21(4):325-328
83. Fassina AS et al (2000) Fine needle aspiration cytology (FNAC) of adrenal masses. Cytopathology 11(5):302-311
84. Habscheid W et al (1990) [Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication?]. Dtsch Med Wochenschr 115(6):212-215
85. Mody MK et al (1995) Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 19(3):434-439
86. de Agustin P, Lopez-Rios F et al (1999) Fine-needle aspiration biopsy of the adrenal glands: a ten-year experience. Diagn Cytopathol 21(2):92-97
87. Katz RL et al (1984) Fine needle aspiration cytology of the adrenal gland. Acta Cytol 28(3):269-282
88. Silverman SG et al (1993) Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 187(3):715-718
89. Wadih G et al (1992) Fine-needle aspiration cytology of the adrenal gland. Fifty biopsies in 48 patients. Arch Pathol Lab Med 116(8):841-846
90. Welch TJ et al (1994) Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193(2):341-344
91. Wu HH et al (1998) Fine needle aspiration cytology of benign adrenal cortical nodules. A comparison of cytologic findings with those of primary and metastatic adrenal malignancies. Acta Cytol 42(6):1352-1358
92. Ren R et al (2006) Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389-398
93. Lumachi F et al (2003) CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29(8):689-692
94. Saeger W et al (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34(2):180-186
95. Jhala NC et al (2004) Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients. Cancer 102(5):308-314
96. Haseganu LE, Diehl DL (2009) Left adrenal gland hemorrhage as a complication of EUS-FNA. Gastrointest Endosc 69(6):e51-52